HIV-1 Genetic Diversity, Tropism and Drug Resistance Mutations among HIV Infected Patients Attending Comprehensive Care Clinic in Kisii Teaching and Referral …

SN Mabeya - 2021 - ir.jkuat.ac.ke
Since the initiation of Kenya's nationwide free antiretroviral therapy (ART) in 2003 and 3 by 5
initiatives the availability of highly active antiretroviral therapy (HAART) has increased …

Factors influencing adherence to antiretroviral therapy among HIV positive adolescents at adult infectious diseases center in Lusaka, Zambia.

HC Namoomba - 2019 - dspace.unza.zm
Adherence to combination antiretroviral therapy leads to restoration of the immune function
and reduces HIV-related adverse outcomes. However non adherence to combination …

Genome-wide scan in two groups of HIV-infected patients treated with dendritic cell-based immunotherapy

R Moura Rodrigues, M Plana, F Garcia, L Zupin… - Immunologic …, 2016 - Springer
We performed a retrospective genome-wide association study in HIV-infected individuals
who were treated with dendritic cell-based immunotherapy in clinical trials performed by two …

Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia

FP Hudson, L Mulenga, AO Westfall… - Antiviral …, 2019 - journals.sagepub.com
Background HIV viral load (VL) and resistance testing are limited in sub-Saharan Africa, so
individuals may have prolonged time on failing first-line antiretroviral therapy (ART). Our …

From bedside to bench and back: future options for antiretroviral drugs in non-B HIV-1 subtypes

DT Njenda - 2020 - search.proquest.com
HIV-1 drug resistance remains a burden in low-and middle-income countries (LMIC).
Regardless of the advances in antiretroviral (ARV) therapy, there is an increase in the trend …

Circulating pre-treatment and acquired HIV drug resistance Mutations in Dar es Salaam, Tanzania

G BARABONA - 2020 - kumadai.repo.nii.ac.jp
Objectives We investigated the prevalence and patterns of pre-treatment and acquired HIV-
drug resistance mutations (DRM) in Tanzania as “treat all” strategy, virological monitoring …

[PDF][PDF] 学位論文

B Godfrey - 2020 - kumadai.repo.nii.ac.jp
Objectives We investigated the prevalence and patterns of pre-treatment and acquired HIV-
drug resistance mutations (DRM) in Tanzania as “treat all” strategy, virological monitoring …